Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001114220-17-000013
Filing Date
2017-07-25
Accepted
2017-07-25 17:00:21
Documents
1
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150101640651405.html 4  
1 FORM 4 wf-form4_150101640651405.xml 4 3664
  Complete submission text file 0001114220-17-000013.txt   4974
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Neylan John F. (Reporting) CIK: 0001640447 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 17980964